The major aim of all vaccination strategies is disease reduction goals by getting high levels of immunity in the targeted group of people via adequate vaccination coverage and vaccine effectiveness. The idea is to boost immune system of individuals to prevent the spread of the disease.
These are some different type of vaccination strategies given below:
Pulse vaccination strategy: The pulse vaccination strategy is the process used to eliminate an epidemic by repeatedly vaccinating a group of people at risk, over a defined age range, until the spread of the microbe has been come to an end. It is mostly used during the time of polio and measles epidemics to quickly end the spread and contain the outbreak.
Ring vaccination: The method of vaccination of all infected individuals in a prescribed area around an outbreak of an infectious disease. The Ring vaccination process helps to controls an outbreak by monitoring and vaccinating a ring of people around each infected individual. The idea is to boost immune system of individuals to prevent the spread of the disease.
Cocooning (immunization): Cocooning process also known as the Cocoon Strategy, is an immunization strategy to protect young child and other vulnerable individuals from the infectious diseases by vaccinating those who are in close contact with them. If the groups of people most likely to transmit an infection are immune, their immunity creates a "cocoon" of protection around the newborn or the vulnerable persons.
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : The importance of post-marketing surveillance and real-world data: For a product to be successful
Regina Au, BioMarketing Insight, United States
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Approaches towards developing and establishing a biomanufacturing research & development, and manufacturing industry in Zimbabwe: A review of the need, potential funding sources, policy development and implementation
Elliot Nyagumbo, Midlands State University, Zimbabwe
Title : Evaluating the immunogenic impact of process impurities in mRNA vaccine production: Establishing integrated control strategies and specifications
Jesse Kuiper, Merck Research Laboratories, United States
Title : Capillary electrophoresis for adjuvanted multivalent recombinant vaccine purity determination
Ashley Prout, Merck, United States
Title : Hypersensitivity and anti-SARS-COV-2 vaccination: A retrospective study of the year 2021 at the University Hospital Center of Tours (France)
Faure Quentin, The Savoie Metropolitan Hospital Center, France
Title : THE HPV vaccination program in Colombia. From a beautiful dream to a nightmare, but hopefully with a bright dawn.
Carlos Castro, Colombian League against cancer, Colombia